How biomarkers can support regulatory rare disease pathways
On February 21, the Biotechnology Innovation Organization’s (BIO) soon-to-be President & CEO, John F. Crowley, joined an event about biomarkers and rare disease regulatory […]
How biomarkers can support regulatory rare disease pathways Read More »